Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × Irinotecan × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 25 Pancreatic Neoplasms 15 Neuroblastoma 9 Neoplasm Metastasis 9 Colonic Neoplasms 7 Stomach Neoplasms 6 Sarcoma, Ewing 6 Rhabdomyosarcoma 5 Rectal Neoplasms 5 Neoplasms 5 Medulloblastoma 4 Esophageal Squamous Cell Carcinoma 4 Sarcoma 3 Recurrence 3 Ovarian Neoplasms 3 Osteosarcoma 3 Esophageal Neoplasms 3 Ependymoma 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Fibrolamellar hepatocellular carcinoma 2 Colorectal Adenocarcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

Capecitabine 3 Oxaliplatin 2 toripalimab 1 tislelizumab 1 spartalizumab 1 Radiotherapy, Intensity-Modulated 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05412082 2026-02-06

SMART TNT

University of Miami

Phase 1 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡